Developing an anti-Campylobacter jejuni vaccine

Immunopharmacology and Immunotoxicology

Volumn 34, Issue 3, 2012, Pages 385-390

  Lucchese, G ^a   Pesce Delfino, A ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Anti CDT vaccine design; Campylobacter jejuni infection; CDT toxin; Diarrhea; GuillainBarr syndrome; Low similarity peptides; Proteomic sequence analysis

Indexed keywords

CYTOLETHAL DISTENDING TOXIN; PENTAPEPTIDE; PROTEOME;

AMINO ACID SEQUENCE; ARTICLE; CAMPYLOBACTER JEJUNI; DRUG DESIGN; HUMAN; IMMUNE RESPONSE; IMMUNOREACTIVITY; IMMUNOTHERAPY; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS;

BACTERIAL TOXINS; BACTERIAL VACCINES; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; HUMANS; PEPTIDES; PROTEOMICS;

CAMPYLOBACTER JEJUNI;

EID: 84860714245     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.3109/08923973.2011.608685     Document Type: Article

References (54)

1. Zhou, M., Robinson, C.V. When proteomics meets structural biology. Trends Biochem Sci 2010, 35, 522-529.
2. Cho, W.C. Proteomics and translational medicine: molecular biomarkers for cancer diagnosis, prognosis and prediction of therapy outcome. Expert Rev Proteomics 2011, 8, 1-4.
3. Mitchell, J.W., Atkins, N. Jr, Sweedler, J.V., Gillette, M.U. Direct cellular peptidomics of hypothalamic neurons. Front Neuroendocrinol 2011.
4. Fogli, A., Bulet, P. Peptidomics analysis of lymphoblastoid cell lines. Methods Mol Biol 2010, 615, 247-257.
5. Stufano, A., Capone, G., Pesetti, B., Polimeno, L., Kanduc, D. Clustering of rare peptide segments in the HCV immunome. Self Nonself 2010, 1, 154-162.
6. Mittelman, A., Lucchese, A., Sinha, A.A., Kanduc, D. Monoclonal and polyclonal humoral immune response to EC HER-2/NEU peptides with low similarity to the host's proteome. Int J Cancer 2002, 98, 741-747. (Pubitemid 34225626)
7. Tiwari, R., Geliebter, J., Lucchese, A., Mittelman, A., Kanduc, D. Computational peptide dissection of Melan-a/MART-1 oncoprotein antigenicity. Peptides 2004, 25, 1865-1871. (Pubitemid 39389180)
8. Mittelman, A., Tiwari, R., Lucchese, G., Willers, J., Dummer, R., Kanduc, D. Identification of monoclonal anti-HMW-MAA antibody linear peptide epitope by proteomic database mining. J Invest Dermatol 2004, 123, 670-675. (Pubitemid 39281607)
9. Dummer, R., Mittelman, A., Fanizzi, F.P., Lucchese, G., Willers, J., Kanduc, D. Non-self-discrimination as a driving concept in the identification of an immunodominant HMW-MAA epitopic peptide sequence by autoantibodies from melanoma cancer patients. Int J Cancer 2004, 111, 720-726. (Pubitemid 39062894)
10. Lucchese, A., Mittelman, A., Lin, M.S., Kanduc, D., Sinha, A.A. Epitope definition by proteomic similarity analysis: identification of the linear determinant of the anti-Dsg3 MAb 5H10. J Transl Med 2004, 2, 43.
11. Lucchese, A., Willers, J., Mittelman, A., Kanduc, D., Dummer, R. Proteomic scan for tyrosinase peptide antigenic pattern in vitiligo and melanoma: role of sequence similarity and HLA-DR1 affinity. J Immunol 2005, 175, 7009-7020. (Pubitemid 41598948)
12. Willers, J., Lucchese, A., Mittelman, A., Dummer, R., Kanduc, D. Definition of anti-tyrosinase MAb T311 linear determinant by proteome-based similarity analysis. Exp Dermatol 2005, 14, 543-550. (Pubitemid 40883413)
13. Kanduc, D. Peptimmunology: immunogenic peptides and sequence redundancy. Curr Drug Discov Technol 2005, 2, 239-244. (Pubitemid 43168115)
14. Kanduc, D. Immunogenicity in peptide-immunotherapy: from self/nonself to similar/dissimilar sequences. Adv Exp Med Biol 2008, 640, 198-207.
15. Kanduc, D. "Self-nonself" peptides in the design of vaccines. Curr Pharm Des 2009, 15, 3283-3289.
16. Kanduc, D. The self/nonself issue: A confrontation between proteomes. Self Nonself 2010, 1, 255-258.
17. Trost, B., Lucchese, G., Stufano, A., Bickis, M., Kusalik, A., Kanduc, D. No human protein is exempt from bacterial motifs, not even one. Self Nonself 2010, 1, 328-334.
18. Kusalik, A., Bickis, M., Lewis, C., Li, Y., Lucchese, G., Marincola, F.M., Kanduc, D. Widespread and ample peptide overlapping between HCV and Homo sapiens proteomes. Peptides 2007, 28, 1260-1267. (Pubitemid 46843388)
19. Kanduc, D., Tessitore, L., Lucchese, G., Kusalik, A., Farber, E., Marincola, F.M. Sequence uniqueness and sequence variability as modulating factors of human anti-HCV humoral immune response. Cancer Immunol Immunother 2008, 57, 1215-1223.
20. Polimeno, L., Mittelman, A., Gennero, L., Ponzetto, A., Lucchese, G., Stufano, A., Kusalik, A., Kanduc, D. Sub-epitopic dissection of HCV E1315-328HRMAWDMMMNWSPT sequence by similarity analysis. Amino Acids 2008, 34, 479-484. (Pubitemid 351569757)
21. Lucchese, G., Stufano, A., Kanduc, D. Proteome-guided search for influenza A B-cell epitopes. FEMS Immunol Med Microbiol 2009, 57, 88-92.
22. Kanduc, D., Serpico, R., Lucchese, A., Shoenfeld, Y. Correlating low-similarity peptide sequences and HIV B-cell epitopes. Autoimmun Rev 2008, 7, 291-296. (Pubitemid 351284547)
23. Lucchese, G., Stufano, A., Kanduc, D. Searching for an effective, safe and universal anti-HIV vaccine: Finding the answer in just one short peptide. Self Nonself 2011, 2, 49-54.
24. Lucchese, G., Stufano, A., Kanduc, D. Proposing low-similarity peptide vaccines against Mycobacterium tuberculosis. J Biomed Biotechnol 2010, 2010, 832341.
25. Blaser, M.J., Wells, J.G., Feldman, R.A., Pollard, R.A., Allen, J.R. Campylobacter enteritis in the United States. A multicenter study. Ann Intern Med 1983, 98, 360-365. (Pubitemid 13158509)
26. Tracz, D.M., Keelan, M., Ahmed-Bentley, J., Gibreel, A., Kowalewska-Grochowska, K., Taylor, D.E. pVir and bloody diarrhea in Campylobacter jejuni enteritis. Emerging Infect Dis 2005, 11, 838-843. (Pubitemid 40720843)
27. Louwen, R.P., van Belkum, A., Wagenaar, J.A., Doorduyn, Y., Achterberg, R., Endtz, H.P. Lack of association between the presence of the pVir plasmid and bloody diarrhea in Campylobacter jejuni enteritis. J Clin Microbiol 2006, 44, 1867-1868. (Pubitemid 43726287)
28. Cunningham, S.A., Sloan, L.M., Nyre, L.M., Vetter, E.A., Mandrekar, J., Patel, R. Three-hour molecular detection of Campylobacter, Salmonella, Yersinia, and Shigella species in feces with accuracy as high as that of culture. J Clin Microbiol 2010, 48, 2929-2933.
29. Walker, R.I. Considerations for development of whole cell bacterial vaccines to prevent diarrheal diseases in children in developing countries. Vaccine 2005, 23, 3369-3385. (Pubitemid 40520524)
30. Gregson, N.A., Rees, J.H., Hughes, R.A. Reactivity of serum IgG anti-GM1 ganglioside antibodies with the lipopolysaccharide fractions of Campylobacter jejuni isolates from patients with Guillain-Barre syndrome (GBS). J Neuroimmunol 1997, 73, 28-36. (Pubitemid 27105266)
31. Yuki, N., Taki, T., Inagaki, F., Kasama, T., Takahashi, M., Saito, K., Handa, S., Miyatake, T. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. J Exp Med 1993, 178, 1771-1775. (Pubitemid 23318456)
32. Perera, V.N., Nachamkin, I., Ung, H., Patterson, J.H., McConville, M.J., Coloe, P.J., Fry, B.N. Molecular mimicry in Campylobacter jejuni: role of the lipo-oligosaccharide core oligosaccharide in inducing anti-ganglioside antibodies. FEMS Immunol Med Microbiol 2007, 50, 27-36. (Pubitemid 46763466)
33. Drenthen, J., Yuki, N., Meulstee, J., Maathuis, E.M., van Doorn, P.A., Visser, G.H., Blok, J.H., Jacobs, B.C. Guillain-Barré syndrome subtypes related to Campylobacter infection. J Neurol Neurosurg Psychiatr 2011, 82, 300-305.
34. White, J.R., Sachs, G.M., Gilchrist, J.M. Multifocal motor neuropathy with conduction block and Campylobacter jejuni. Neurology 1996, 46, 562-563. (Pubitemid 26081353)
35. Smith, J.L. Campylobacter jejuni infection during pregnancy: long-term consequences of associated bacteremia, Guillain-Barré syndrome, and reactive arthritist. J Food Prot 2002, 65, 696-708. (Pubitemid 34294220)
36. http://www.cdc.gov/nczved/divisions/dfbmd/diseases/ campylobacter/ technical.html#incidence 37
37. Dasti, J.I., Tareen, A.M., Lugert, R., Zautner, A.E., Gross, U. Campylobacter jejuni: a brief overview on pathogenicityassociated factors and disease-mediating mechanisms. Int J Med Microbiol 2010, 300, 205-211.
38. Ge, Z., Schauer, D.B., Fox, J.G. In vivo virulence properties of bacterial cytolethal-distending toxin. Cell Microbiol 2008, 10, 1599-1607. (Pubitemid 352006144)
39. Zheng, J., Meng, J., Zhao, S., Singh, R., Song, W. Campylobacterinduced interleukin-8 secretion in polarized human intestinal epithelial cells requires Campylobacter-secreted cytolethal distending toxin- and Toll-like receptor-mediated activation of NF-kappaB. Infect Immun 2008, 76, 4498-4508.
40. Jain, D., Prasad, K.N., Sinha, S., Husain, N. Differences in virulence attributes between cytolethal distending toxin positive and negative Campylobacter jejuni strains. J Med Microbiol 2008, 57, 267-272. (Pubitemid 351358528)
41. Jain, D., Prasad, K.N., Sinha, S., Vishwakarma, A.L. Cell cycle arrest & apoptosis of epithelial cell line by cytolethal distending toxin positive Campylobacter jejuni. Indian J Med Res 2009, 129, 418-423.
42. Wu, C.H., Yeh, L.S., Huang, H., Arminski, L., Castro-Alvear, J., Chen, Y., Hu, Z., Kourtesis, P., Ledley, R.S., Suzek, B.E., Vinayaka, C.R., Zhang, J., Barker, W.C. The Protein Information Resource. Nucleic Acids Res 2003, 31, 345-347. (Pubitemid 36150400)
43. Lucchese, G., Stufano, A., Trost, B., Kusalik, A., Kanduc, D. Peptidology: short amino acid modules in cell biology and immunology. Amino Acids 2007, 33, 703-707. (Pubitemid 350165425)
44. Hatakeyama, J., Bessho, Y., Katoh, K., Ookawara, S., Fujioka, M., Guillemot, F., Kageyama, R. Hes genes regulate size, shape and histogenesis of the nervous system by control of the timing of neural stem cell differentiation. Development 2004, 131, 5539-5550. (Pubitemid 39625198)
45. Petrou, P., Makrygiannis, A.K., Chalepakis, G. The Fras1/Frem family of extracellular matrix proteins: structure, function, and association with Fraser syndrome and the mouse bleb phenotype. Connect Tissue Res 2008, 49, 277-282.
46. Jun, D.J., Na, K.Y., Kim, W., Kwak, D., Kwon, E.J., Yoon, J.H., Yea, K., Lee, H., Kim, J., Suh, P.G., Ryu, S.H., Kim, K.T. Melanocortins induce interleukin 6 gene expression and secretion through melanocortin receptors 2 and 5 in 3T3-L1 adipocytes. J Mol Endocrinol 2010, 44, 225-236.
47. Hunt, S.C., Xin, Y., Wu, L.L., Cawthon, R.M., Coon, H., Hasstedt, S.J., Hopkins, P.N. Sodium bicarbonate cotransporter polymorphisms are associated with baseline and 10-year follow-up blood pressures. Hypertension 2006, 47, 532-536. (Pubitemid 43843871)
48. Lobley, A., Pierron, V., Reynolds, L., Allen, L., Michalovich, D. Identification of human and mouse CatSper3 and CatSper4 genes: characterisation of a common interaction domain and evidence for expression in testis. Reprod Biol Endocrinol 2003, 1, 53.
49. Kurima, K., Yang, Y., Sorber, K., Griffith, A.J. Characterization of the transmembrane channel-like (TMC) gene family: functional clues from hearing loss and epidermodysplasia verruciformis. Genomics 2003, 82, 300-308. (Pubitemid 36952303)
50. Maiti, A.K., Mattéi, M.G., Jorissen, M., Volz, A., Zeigler, A., Bouvagnet, P. Identification, tissue specific expression, and chromosomal localisation of several human dynein heavy chain genes. Eur J Hum Genet 2000, 8, 923-932. (Pubitemid 32094343)
51. Dib-Hajj, S.D., Tyrrell, L., Cummins, T.R., Black, J.A., Wood, P.M., Waxman, S.G. Two tetrodotoxin-resistant sodium channels in human dorsal root ganglion neurons. FEBS Lett 1999, 462, 117-120.
52. Tam, C.C., O'Brien, S.J., Petersen, I., Islam, A., Hayward, A., Rodrigues, L.C. Guillain-Barré syndrome and preceding infection with campylobacter, influenza and Epstein-Barr virus in the general practice research database. PLoS ONE 2007, 2, e344.
53. Poropatich, K.O., Walker, C.L., Black, R.E. Quantifying the association between Campylobacter infection and Guillain-Barré syndrome: a systematic review. J Health Popul Nutr 2010, 28, 545-552.
54. Kanduc, D., Lucchese, A., Mittelman, A. Non-redundant peptidomes from DAPs: towards "the vaccine"? Autoimmun Rev 2007, 6, 290-294. (Pubitemid 46507994)